Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective.

Author: AsgharnejadMahnaz, BauerLars, BenitezArturo, BoroojerdiBabak, ChungSun Ju, HeidbredeTanja, KimHan Joon, LittleAllison

Paper Details 
Original Abstract of the Article :
Dopamine receptor agonists (DAs) are commonly used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). In certain situations, switching from oral DAs to rotigotine transdermal patch may be beneficial for the patient (e.g., optimal symptom control/side effects/perioperative management...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/14737175.2017.1336087

データ提供:米国国立医学図書館(NLM)

Switching Dopamine Receptor Agonists: A Patient-Centered Approach

This research explores the field of neurology, specifically focusing on the management of Parkinson's disease (PD) and restless legs syndrome (RLS) using dopamine receptor agonists (DAs). The study examines the clinical considerations for switching from oral DAs to rotigotine transdermal patch, highlighting the potential benefits for patients seeking alternative treatment options. The authors discuss the dose equivalency, conversion schedules, safety, tolerability, efficacy, and patient preferences associated with switching between oral DAs and rotigotine. The study provides a comprehensive overview of the practical considerations for switching between these DA medications.

Finding the Right Path: Navigating DA Switch

This study, much like a camel navigating a complex desert landscape, explores the complexities of switching between dopamine receptor agonists for PD and RLS patients. The research underscores the importance of individualizing treatment approaches, considering patient preferences and clinical considerations when transitioning between DA medications.

Optimizing DA Therapy for Improved Patient Outcomes

The study's findings offer valuable insights for clinicians seeking to optimize DA therapy for PD and RLS patients. The research highlights the need for a patient-centered approach, considering individual patient needs and preferences when making treatment decisions. This study encourages further investigation into the optimal strategies for switching between different DA medications, ensuring a smooth transition and improved outcomes for patients.

Dr.Camel's Conclusion

This research, much like a camel guiding a caravan through the desert, explores the clinical considerations for switching between dopamine receptor agonists. The study's findings emphasize the importance of individualizing treatment approaches, prioritizing patient preferences and clinical considerations to achieve the best possible outcomes.

Date :
  1. Date Completed 2019-01-03
  2. Date Revised 2019-01-03
Further Info :

Pubmed ID

28548894

DOI: Digital Object Identifier

10.1080/14737175.2017.1336087

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.